For: | Murphy CK, O’Donnell MM, Hegarty JW, Schulz S, Hill C, Ross RP, Rea MC, Farquhar R, Chesnel L. Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against Clostridioides difficile infection challenge in vivo. World J Gastrointest Pathophysiol 2023; 14(4): 71-85 [PMID: 37727283 DOI: 10.4291/wjgp.v14.i4.71] |
---|---|
URL: | https://www.wjgnet.com/2150-5330/full/v14/i4/71.htm |
Number | Citing Articles |
1 |
Mithu Howlader, Shuvo Chandra Das, Shipan Das Gupta, Dhirendra Nath Barman, Mohammed Mafizul Islam, Md. Easin Mia, Md. Salahuddin, Md. Murad Hossain. An Insight into Bacteriocins for Combating Microbial Infections and Ensuring Food Safety. International Journal of Peptide Research and Therapeutics 2025; 31(2) doi: 10.1007/s10989-025-10691-5
|
2 |
Sophie Irwin, Andrea Chupina Estrada, Becca Nelson, Ashlen Bullock, Berkeley Limketkai, Wendy Ho, Susan Acton, Laurent Chesnel, Hon Wai Koon. ADS024, a single-strain live biotherapeutic product of Bacillus velezensis alleviates dextran sulfate-mediated colitis in mice, protects human colonic epithelial cells against apoptosis, and maintains epithelial barrier function. Frontiers in Microbiology 2024; 14 doi: 10.3389/fmicb.2023.1284083
|
3 |
Ivan Sugrue, R. Paul Ross, Colin Hill. Bacteriocin diversity, function, discovery and application as antimicrobials. Nature Reviews Microbiology 2024; 22(9): 556 doi: 10.1038/s41579-024-01045-x
|
4 |
Susan Acton, Michelle M. O’Donnell, Kalaichitra Periyasamy, Bharat Dixit, Haifeng Eishingdrelo, Colin Hill, R. Paul Ross, Laurent Chesnel. LPA3 agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory disease models. Brain, Behavior, and Immunity 2024; 121: 384 doi: 10.1016/j.bbi.2024.08.024
|